NasdaqGS - Nasdaq Real Time Price USD
Collegium Pharmaceutical, Inc. (COLL)
29.96
+0.13
+(0.44%)
At close: 4:00:01 PM EDT
29.96
0.00
(0.00%)
After hours: 4:30:30 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | 1.83 | 2.01 | 7.62 | 7.74 |
| Low Estimate | 1.62 | 1.71 | 6.76 | 6.35 |
| High Estimate | 2.55 | 2.84 | 10.6 | 10.67 |
| Year Ago EPS | 1.62 | 1.61 | 6.45 | 7.62 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 5 | 5 |
| Avg. Estimate | 182.26M | 189.13M | 743.82M | 770.65M |
| Low Estimate | 181.98M | 187.8M | 740.5M | 747.3M |
| High Estimate | 182.4M | 191.5M | 749.2M | 800.8M |
| Year Ago Sales | 145.28M | 159.3M | 631.45M | 743.82M |
| Sales Growth (year/est) | 25.46% | 18.73% | 17.80% | 3.61% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 1.49 | 1.59 | 1.54 | 1.45 |
| EPS Actual | 1.62 | 1.61 | 1.77 | 1.49 |
| Difference | 0.13 | 0.02 | 0.23 | 0.04 |
| Surprise % | 9.02% | 1.10% | 15.12% | 2.76% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 1.83 | 2.01 | 7.62 | 7.74 |
| 7 Days Ago | 1.62 | 1.83 | 6.91 | 7.29 |
| 30 Days Ago | 1.63 | 1.81 | 6.91 | 7.29 |
| 60 Days Ago | 1.66 | 1.81 | 6.97 | 7.34 |
| 90 Days Ago | 1.56 | 1.65 | 6.53 | 7.15 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| COLL | 12.96% | 25.09% | 18.17% | 1.57% |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Upgrades & Downgrades
| Reiterates | Piper Sandler: Neutral to Neutral | 5/9/2025 |
| Reiterates | Needham: Buy to Buy | 4/9/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/24/2025 |
| Maintains | Piper Sandler: Neutral to Neutral | 2/4/2025 |
| Upgrade | Needham: Hold to Buy | 1/10/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/10/2025 |
Related Tickers
SUPN Supernus Pharmaceuticals, Inc.
33.20
+0.45%
INDV Indivior PLC
11.44
-2.05%
ANIK Anika Therapeutics, Inc.
11.96
-1.64%
CPIX Cumberland Pharmaceuticals Inc.
5.03
-7.71%
PCRX Pacira BioSciences, Inc.
26.75
+2.29%
AMPH Amphastar Pharmaceuticals, Inc.
25.07
+1.13%
ANIP ANI Pharmaceuticals, Inc.
60.64
+0.80%
IRWD Ironwood Pharmaceuticals, Inc.
0.6524
+6.62%
ETON Eton Pharmaceuticals, Inc.
19.60
+0.15%
SIGA SIGA Technologies, Inc.
6.20
+2.23%